Skip to content

Integra Lifesciences Holdings Corp

IART· NasdaqCore metricsCIK 917520

Surgical & medical instruments & apparatus143 peers

Last sale
Nov 12, 2026 · -2.81%
Market cap
$1.12B
77.8M shares
Filings
1,035
$411.18M
Q3 2026+1.5% FY25 yoy
$14.85M
Q3 2026N/M FY25 yoy
$18.90M
Q3 2026N/M FY25 yoy
$91.18M
Q3 2026derivedN/M FY25 yoy
$0.19
Q3 2026N/M FY25 yoy
$252.26M
Q3 2026−4.6% FY25 yoy
$1.12B
85.8×
0.7×
1.0×
7.68%
—

Twelve months to Sep 30, 2026 · derived

Price

$14.36+16.42%+$2.03past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$1.64BFY 2025
$1.64B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$1,635,245,000reported
FY 20242024-12-31$1,610,527,000reported
FY 20232023-12-31$1,541,573,000reported
FY 20222022-12-31$1,557,666,000reported
FY 20212021-12-31$1,542,448,000reported
FY 20202020-12-31$1,371,868,000reported
FY 20192019-12-31$1,517,557,000reported
FY 20182018-12-31$1,472,441,000reported
FY 20172017-12-31$1,188,236,000reported
FY 20162016-12-31$992,075,000reported
FY 20152015-12-31$882,734,000reported
FY 20142014-12-31$796,717,000 revisedreported

Capital returns

Dividends and buybacks · FY2012 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$221.00K$221.00K—77.94M sh+0.9%—
FY2024—$52.47M$52.47M—77.22M sh−1.3%210.2%
FY2023—$275.00M$275.00M—78.22M sh−4.2%376.2%
FY2022—$125.00M$125.00M—81.64M sh−1.9%56.3%
FY2021—$0.00$0.00—83.24M sh−1.3%0.0%

Segments

Revenue by Segments, FY2018 to FY2025FY2018Codman Specialty Surgical · FY2018 · $963.93MOrthopedics and Tissue Technologies · FY2018 · $508.51MFY2019Codman Specialty Surgical · FY2019 · $996.21MTissue Technologies · FY2019 · $521.35MOrthopedics and Tissue Technologies · FY2019 · $521.35MFY2020Codman Specialty Surgical · FY2020 · $894.83MTissue Technologies · FY2020 · $477.04MOrthopedics and Tissue Technologies · FY2020 · $477.04MFY2021Codman Specialty Surgical · FY2021 · $1.03BTissue Technologies · FY2021 · $517.22MFY2022Codman Specialty Surgical · FY2022 · $1.02BTissue Technologies · FY2022 · $538.10MFY2023Codman Specialty Surgical · FY2023 · $1.06BTissue Technologies · FY2023 · $482.58MFY2024Codman Specialty Surgical · FY2024 · $1.14BTissue Technologies · FY2024 · $466.89MFY2025Codman Specialty Surgical · FY2025 · $1.20BTissue Technologies · FY2025 · $434.73M
LineFY2025ShareChange
Codman Specialty Surgical$1.20B73%+5.0%
Tissue Technologies$434.73M27%−6.9%
Orthopedics and Tissue Technologies———
Total$1.64B

From the 10-K filed Feb 26, 2026IART

Surgical & medical instruments & apparatus

Integra Lifesciences Holdings Corp is the 16th largest of the 144 covered companies the SEC files under this code, by revenue. SIC 3841

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR